SUR116—3c/t基因多态性与2型糖尿病关系的meta分析
摘要
目的阐明SURl16—3c/t基因多态性与2型糖尿病的相关性。方法以PubMed、CNKI、VIP等为搜索数据库,检索2014年3月以前发表的有关SURl16—3c/t基因多态性与T2DM相关性的随机病例对照研究,并用stata12.0软件进行统计分析且比较。结果纳入10篇文献共11对病例对照符合条件,数据合并结果显示病例组T等位基因频率较对照组的高OR=1.1095%CI(0.98-1.22)(P=0.117〉0.01)。结论SURl基因16号外显子3c/t的多态性在T2DM和健康人群之间差异无统计学意义(P〉0.05),C等位基因可能不是2型糖尿病发生的易感基因。
出处
《检验医学与临床》
CAS
2014年第A02期251-253,共3页
Laboratory Medicine and Clinic
参考文献9
-
1陈凤玲,史文静,张晓梅,李荣英,宋怀东,胡仁明,陈家伦.磺脲类药物受体1基因多态性与2型糖尿病相关性[J].中华内分泌代谢杂志,2003,19(5):371-374. 被引量:8
-
2王劲松,周玲,成金罗,沈默宇.磺酰脲类受体基因多态性与2型糖尿病的相关性研究[J].遗传,2004,26(1):8-12. 被引量:9
-
3Gloyn AL,Hashim Y,AshcroftSJ,etal.Associationstudiesofvariantsinpromoterandcodingregionsofbe-ta-cellATP-sensitiveK-channelgenesSUR1andKir6.2withtype2diabetes mellitus (UKPDS53)[J].DiabetMed,2001,18(11),206-212.
-
4HansenT,EchwaldSM,HansenT,etal.Decreasedtol-butamlde-stimulatedinsulinsecretioninhealthysubjectswithsequencevariantsinthehigh-affinitysutfonylureareceptorgene[J].Diabetes,1998,47(27):598-605.
-
5GloynAL,Weedon MN,OwenKR,etal.Large-scaleas-sociationstudiesofvariantsingenesencodingthepancre-aticbeta-cellKATPchannelsubunitsKir6.2 (KCNJ11)andSUR1 (ABCC8)confirmthattheKCNJ11E23Kva-riantisas-sociated withtype2 diabetes[J].Diabetes,2003,52(31):568-572.
-
6HartLM,HaeftenTW van,DekkerJM,etal.VariationsininsulinsecretionincarriersoftheE23KvariantintheKIR6.2subunitoftheATP-sensitiveK(+)channelinthebeta-cell[J].Diabetes,2002,51(16):3135-3138.
-
7ReisAF,YeWZ,Dubois-LaforgueD,etal.Associationofavariantionexon31ofthesulfonylureareceptor1(SURl)genewithtype2diabetes mellitusinFrench Cau-casians[J].HumGenet,2000,107(74):138-144.
-
8WangF,HanXY,RenQ,etal.Effectofgeneticvar-iantsinKCNJ11,ABCC8,PPARGandHNF4Alocionthesus-ceptibilityoftype2diabetesinChinese Hanpopulation[J].Chin MedJ(Engl),2009,122(17):2477-2482.
-
9Both C.Kawaljit Matharoo Association ofadiponectin(AdipoQ)andsulphonylureareceptor (ABCC8)genepolymorphismswith Type2 Diabetesin NorthIndianpopulationofPunjab[J].SciVerseScienceDirect,2013,527(52):228-234.
二级参考文献22
-
1[1]Inagaki N,Gonoi T,Clement J P I,Namba N,Inazawa J,Gonzalez G,Aguilar B L,Seino S,Bryan J.Reconstitution of IKATP:an inward rectifier subunit plus the sulfonylurea recep- tor.Science,1995,270:1166~1170.
-
2[4]Hani E H,Clement K,Velho G,Vionnet N,Hager J,Philippi A,Dina C,Inoue H,Permutt M A,Basdevant A,North M,De menais F,Guy Grand B,Froguel P.Genetic studies of the sul fonylurea receptor gene locus in NIDDM and in morbid obesity among French Caucasians.Diabetes,1997,46:688~ 694.
-
3[5]Inoue H,Ferrer J,Welling C M,Elbein S C,Hoffman M,May orga R,Warren P M,Zhang Y,Millns H,Turner R,Province M,Bryan J,Permutt M A,Aguilar B L.Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians.Diabetes,1996,45:825~831.
-
4[6]Reis A F,Ye W Z,Laforgue D D,Bellanne C C,Timsit J,Velho G.Association of a variant in exon31 of the sulfonylurea re ceptor (SUR1) gene with type 2 diabetes mellitus in French Caucasians.Hum Genet,2000,107:138~144.
-
5[7]Hasen T,Echwald S M,Hansen L,Moller A M,Almind K,Clausen J O,Urhammer S A,Inoue H,Ferrer J,Bryan J,Agu ilar B L,Permutt M A,Pedersen O.Decreased tolbutamide stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene.Diabe tes,1998,47:598~605.
-
6[8]Ohta Y,Tanizawa Y,Inoue H,Hosaka T,Ueda K,Matsutani A,Repunte V P,Yamada M,Kurachi Y,Bryan J,Aguilar B L,Permutt M A,Oka Y.Identification and functional analysis of sulfonylurea receptor 1 variants in Japanese patients with NIDDM.Diabetes,1998,47:476 ~ 481.
-
7[9]Horvath S,Laird N M.A discordant-sibship test for disequilib rium and linkage:no need for parental data.Am J Hum Genet,1998,63:1886~1897.
-
8[10]Thomas P M,Cote G J,Wohlk N,Haddad B,Mathew P M,Rabl W,Aguilar B L,Gagel R F,Bryan J.Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy.Science,1995,268:426 ~429.
-
9[11]Boehnke M,Langefeld C D.Genetics association mapping based on discordant sib pairs:the discordant-alleles test.Am J Hum Genet,1998,62:950~961.
-
10RISSANEN J;Markkanen A;Karkkainen P.Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin[J],2000(1).
共引文献12
-
1汪纯,吴国亭,于永春,滕小洪,王吉影,李文君,韩玉麒,顾耀,王艳波.磺脲受体1基因多态性与2型糖尿病相关性家系研究[J].中华内分泌代谢杂志,2005,21(5):446-447. 被引量:1
-
2彭姝彬,熊国梅,苏燕,黄青阳.磺酰脲受体1基因多态性与2型糖尿病的相关性[J].现代生物医学进展,2006,6(11):54-55. 被引量:3
-
3张慧娟,刘晓民,匡洪宇,孙宏,邢厚恂.磺脲受体1基因外显子16-3c/t多态性与格列齐特降血糖的关系[J].中国临床药理学杂志,2007,23(5):369-371. 被引量:1
-
4张慧娟,刘晓民,伊然,匡洪宇,刑厚恂.磺酰脲类药物受体1基因多态性与格列齐特疗效的研究[J].中国糖尿病杂志,2007,15(11):674-675.
-
5王劲松,成金罗,周金意,沈默宇,周玲.PEA15与KCNJ10基因两个单核苷酸位点在2型糖尿病家系成员中的多态性研究[J].中国糖尿病杂志,2007,15(12):722-723.
-
6韩国平,母义明,邹效漫,汪保安,窦京涛,陆菊明.一个2型糖尿病家系ATP敏感性钾通道基因突变分析[J].中国糖尿病杂志,2008,16(1):31-35.
-
7王璐,邸阜生,杨莉,高伟.2型糖尿病患者磺脲类受体1基因多态性与血脂的相关性研究[J].中国综合临床,2008,24(10):1041-1042.
-
8冯清,闵运兵,陈敦金,胡丙杰.KCNJ11和SUR1基因多态性与广东汉族人妊娠糖尿病的相关性[J].广东医学,2010,31(12):1571-1574. 被引量:3
-
9徐嘉宜,杨志宏,于德民,孙丽荣.SUR1基因多态性与格列齐特降糖疗效的相关性分析[J].天津医科大学学报,2010,16(3):459-462. 被引量:1
-
10陈静,华之卉,宋洪涛.口服降糖药物基因组学研究概述[J].中国药师,2011,14(5):728-731.
-
1薛世聪,刘忠民,石宗盛.亚洲地区KCNJ11 E23K基因多态性与2型糖尿病关系的Meta分析[J].检验医学与临床,2015,12(18):2718-2719. 被引量:2
-
2孙永生,吴燕岚.室上性心动过速综合性中西医结合防治的疗效观察[J].中国中西医结合急救杂志,2003,10(2):107-107. 被引量:5
-
3占宏静,陈浩云,林彩霞,张成方,邝山,曾志宏,朱样环.盐酸小檗碱对T2DM合并高脂血症患者血清NO水平及SOD活性的影响[J].北方药学,2015,12(4):119-121. 被引量:8
-
4石洁,朱岩昆,郑丹薇,马晓光,王少华,李辉,邢进,吴彩霞.维生素D受体基因rs2222570位点多态性与结核发病相关性的meta分析[J].郑州大学学报(医学版),2016,51(6):774-779. 被引量:4
-
5赵建,刘红辉,许永玲.阿托伐他汀对2型糖尿病患者血脂及氧化应激的影响[J].医学临床研究,2010,27(2):303-304. 被引量:3
-
6戴宝泉,袁训涛,刘锦铭.血清降钙素原在指导抗生素治疗儿童下呼吸道感染中的价值[J].中国当代儿科杂志,2015,17(12):1292-1296. 被引量:24
-
7田虹,王洪霞.老年脓毒症患者凝血功能紊乱及与预后的关系[J].中国急救医学,2014,34(11):966-969. 被引量:19
-
8姚金科,胡才学,吴耿刚,何文广.非毒性结节性甲状腺肿蛋白质表达差异的初步研究[J].中国医药科学,2013,3(24):23-25. 被引量:1
-
9Alison grant,Philip Gothard,GUY Thwaites,范永德(译),张燕(译),赵艳平(译),何广学(校).耐药结核病的管理[J].英国医学杂志中文版,2008,11(6):351-356.
-
10张晰,朱秋玲.体外反搏治疗非增生型糖尿病视网膜病变的疗效观察[J].中华眼底病杂志,2016,32(2):144-148. 被引量:2